Postpartum skin changes aren't just physical; they can affect your self-confidence. The good news is most are temporary and ...

Among patients with moderate to severe atopic dermatitis, atopic comorbidities did not change the benefits seen with lebrikizumab, according to data published in Annals of Allergy, Asthma & Immunology ...

We spoke to dermatologists and conducted research to select the best lotions for eczema, including picks from Eucerin, Gold ...

The two-time U.S. Olympic gold medalist gymnast opens up about her skin condition, her fashion dos and don’ts for eczema, and ...

Millions of Brits with eczema are almost twice as likely to suffer agonising eye and bowel conditions, research suggests.

Every 1 in 2 Indians is affected by very dry skin in winter. Here is how certain natural remedies can benefit your skin and ...

BRITS have been urged to be vigilant after a surge in cases of a highly infectious Victorian disease that can trigger ...

With the temperatures dropping and the heating turned up, winter can be a difficult time for people who suffer from eczema. It is thought that around 8 million people in the United Kingdom have the ...

Carrie Madormo, RN, MPH, is a health writer. She has over a decade of experience as a registered nurse, practicing in a variety of fields, such as pediatrics, oncology, chronic pain, and public health ...

Johnson & Johnson said on Friday it discontinued a mid-stage study of its experimental drug to treat patients with moderate to severe atopic dermatitis after it failed to meet efficacy goals in an ...

Jonathan Wosen is STAT’s West Coast biotech & life sciences reporter. You can reach Jonathan on Signal at jwosen.27. Kymera Therapeutics reported on Monday that, for the second time this year, it has ...

An international team of investigators has reported results from the first Phase III clinical trials of rocatinlimab, a novel treatment for moderate-to-severe atopic dermatitis (eczema). The findings ...